Logo image of AED.BR

AEDIFICA (AED.BR) Stock Fundamental Analysis

Europe - EBR:AED - BE0003851681 - REIT

62.95 EUR
-0.2 (-0.32%)
Last: 9/19/2025, 7:00:00 PM
Fundamental Rating

4

AED gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 40 industry peers in the Diversified REITs industry. There are concerns on the financial health of AED while its profitability can be described as average. While showing a medium growth rate, AED is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

AED had positive earnings in the past year.
In the past year AED had a positive cash flow from operations.
AED had positive earnings in each of the past 5 years.
In the past 5 years AED always reported a positive cash flow from operatings.
AED.BR Yearly Net Income VS EBIT VS OCF VS FCFAED.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

AED's Return On Assets of 2.73% is in line compared to the rest of the industry. AED outperforms 55.00% of its industry peers.
AED has a Return On Equity of 4.96%. This is comparable to the rest of the industry: AED outperforms 50.00% of its industry peers.
AED has a Return On Invested Capital (3.52%) which is in line with its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for AED is in line with the industry average of 3.43%.
The 3 year average ROIC (3.33%) for AED is below the current ROIC(3.52%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.73%
ROE 4.96%
ROIC 3.52%
ROA(3y)3.01%
ROA(5y)3.48%
ROE(3y)5.47%
ROE(5y)6.57%
ROIC(3y)3.33%
ROIC(5y)3.26%
AED.BR Yearly ROA, ROE, ROICAED.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

Looking at the Profit Margin, with a value of 49.82%, AED is in the better half of the industry, outperforming 67.50% of the companies in the same industry.
AED's Profit Margin has declined in the last couple of years.
AED has a better Operating Margin (77.70%) than 72.50% of its industry peers.
In the last couple of years the Operating Margin of AED has remained more or less at the same level.
Looking at the Gross Margin, with a value of 97.93%, AED belongs to the top of the industry, outperforming 95.00% of the companies in the same industry.
In the last couple of years the Gross Margin of AED has remained more or less at the same level.
Industry RankSector Rank
OM 77.7%
PM (TTM) 49.82%
GM 97.93%
OM growth 3Y1.55%
OM growth 5Y0.91%
PM growth 3Y-20.75%
PM growth 5Y-10.29%
GM growth 3Y0.24%
GM growth 5Y0.4%
AED.BR Yearly Profit, Operating, Gross MarginsAED.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80 100

1

2. Health

2.1 Basic Checks

AED has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, AED has about the same amount of shares outstanding.
Compared to 5 years ago, AED has more shares outstanding
The debt/assets ratio for AED is higher compared to a year ago.
AED.BR Yearly Shares OutstandingAED.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
AED.BR Yearly Total Debt VS Total AssetsAED.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

AED has an Altman-Z score of 0.78. This is a bad value and indicates that AED is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of AED (0.78) is worse than 60.00% of its industry peers.
The Debt to FCF ratio of AED is 24.91, which is on the high side as it means it would take AED, 24.91 years of fcf income to pay off all of its debts.
AED has a worse Debt to FCF ratio (24.91) than 75.00% of its industry peers.
A Debt/Equity ratio of 0.58 indicates that AED is somewhat dependend on debt financing.
The Debt to Equity ratio of AED (0.58) is better than 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 24.91
Altman-Z 0.78
ROIC/WACC0.59
WACC5.99%
AED.BR Yearly LT Debt VS Equity VS FCFAED.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

AED has a Current Ratio of 0.35. This is a bad value and indicates that AED is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.35, AED is doing worse than 62.50% of the companies in the same industry.
A Quick Ratio of 0.35 indicates that AED may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.35, AED is doing worse than 60.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.35
Quick Ratio 0.35
AED.BR Yearly Current Assets VS Current LiabilitesAED.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 59.71% over the past year.
The Earnings Per Share has been decreasing by -7.20% on average over the past years.
AED shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.70%.
AED shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 23.35% yearly.
EPS 1Y (TTM)59.71%
EPS 3Y-18.35%
EPS 5Y-7.2%
EPS Q2Q%-24.33%
Revenue 1Y (TTM)8.7%
Revenue growth 3Y13.45%
Revenue growth 5Y23.35%
Sales Q2Q%4.94%

3.2 Future

AED is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.09% yearly.
AED is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.08% yearly.
EPS Next Y3.38%
EPS Next 2Y3.11%
EPS Next 3Y3.09%
EPS Next 5YN/A
Revenue Next Year6.24%
Revenue Next 2Y5.36%
Revenue Next 3Y5.08%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AED.BR Yearly Revenue VS EstimatesAED.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
AED.BR Yearly EPS VS EstimatesAED.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 17.01, which indicates a rather expensive current valuation of AED.
AED's Price/Earnings ratio is in line with the industry average.
AED's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.38.
With a Price/Forward Earnings ratio of 12.03, AED is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AED indicates a slightly more expensive valuation: AED is more expensive than 60.00% of the companies listed in the same industry.
AED's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.86.
Industry RankSector Rank
PE 17.01
Fwd PE 12.03
AED.BR Price Earnings VS Forward Price EarningsAED.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

AED's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. AED is more expensive than 65.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, AED is valued more expensive than 80.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 28.88
EV/EBITDA 19.92
AED.BR Per share dataAED.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of AED may justify a higher PE ratio.
PEG (NY)5.04
PEG (5Y)N/A
EPS Next 2Y3.11%
EPS Next 3Y3.09%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.35%, AED is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 5.57, AED is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.38, AED pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.35%

5.2 History

On average, the dividend of AED grows each year by 22.82%, which is quite nice.
Dividend Growth(5Y)22.82%
Div Incr Years1
Div Non Decr Years1
AED.BR Yearly Dividends per shareAED.BR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

AED pays out 105.58% of its income as dividend. This is not a sustainable payout ratio.
The dividend of AED is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP105.58%
EPS Next 2Y3.11%
EPS Next 3Y3.09%
AED.BR Yearly Income VS Free CF VS DividendAED.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M
AED.BR Dividend Payout.AED.BR Dividend Payout, showing the Payout Ratio.AED.BR Dividend Payout.PayoutRetained Earnings

AEDIFICA

EBR:AED (9/19/2025, 7:00:00 PM)

62.95

-0.2 (-0.32%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)07-30 2025-07-30
Earnings (Next)10-28 2025-10-28
Inst Owners40.83%
Inst Owner ChangeN/A
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap2.99B
Analysts76.67
Price Target74.94 (19.05%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.35%
Yearly Dividend3.51
Dividend Growth(5Y)22.82%
DP105.58%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.13%
PT rev (3m)1.68%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.98%
EPS NY rev (3m)0.98%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.17%
Revenue NY rev (3m)0.23%
Valuation
Industry RankSector Rank
PE 17.01
Fwd PE 12.03
P/S 8.48
P/FCF 28.88
P/OCF 10.25
P/B 0.84
P/tB 0.87
EV/EBITDA 19.92
EPS(TTM)3.7
EY5.88%
EPS(NY)5.23
Fwd EY8.32%
FCF(TTM)2.18
FCFY3.46%
OCF(TTM)6.14
OCFY9.76%
SpS7.42
BVpS74.59
TBVpS72.74
PEG (NY)5.04
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.73%
ROE 4.96%
ROCE 4.69%
ROIC 3.52%
ROICexc 3.55%
ROICexgc 3.61%
OM 77.7%
PM (TTM) 49.82%
GM 97.93%
FCFM 29.37%
ROA(3y)3.01%
ROA(5y)3.48%
ROE(3y)5.47%
ROE(5y)6.57%
ROIC(3y)3.33%
ROIC(5y)3.26%
ROICexc(3y)3.34%
ROICexc(5y)3.28%
ROICexgc(3y)3.4%
ROICexgc(5y)3.38%
ROCE(3y)4.43%
ROCE(5y)4.34%
ROICexcg growth 3Y6.29%
ROICexcg growth 5Y0.95%
ROICexc growth 3Y7%
ROICexc growth 5Y0.65%
OM growth 3Y1.55%
OM growth 5Y0.91%
PM growth 3Y-20.75%
PM growth 5Y-10.29%
GM growth 3Y0.24%
GM growth 5Y0.4%
F-Score7
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 24.91
Debt/EBITDA 7.41
Cap/Depr 6078.86%
Cap/Sales 53.38%
Interest Coverage 250
Cash Conversion 105.31%
Profit Quality 58.95%
Current Ratio 0.35
Quick Ratio 0.35
Altman-Z 0.78
F-Score7
WACC5.99%
ROIC/WACC0.59
Cap/Depr(3y)11089%
Cap/Depr(5y)16628.2%
Cap/Sales(3y)126.51%
Cap/Sales(5y)150.79%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)59.71%
EPS 3Y-18.35%
EPS 5Y-7.2%
EPS Q2Q%-24.33%
EPS Next Y3.38%
EPS Next 2Y3.11%
EPS Next 3Y3.09%
EPS Next 5YN/A
Revenue 1Y (TTM)8.7%
Revenue growth 3Y13.45%
Revenue growth 5Y23.35%
Sales Q2Q%4.94%
Revenue Next Year6.24%
Revenue Next 2Y5.36%
Revenue Next 3Y5.08%
Revenue Next 5YN/A
EBIT growth 1Y9.49%
EBIT growth 3Y15.21%
EBIT growth 5Y24.47%
EBIT Next Year12.16%
EBIT Next 3Y6.92%
EBIT Next 5YN/A
FCF growth 1Y142.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y18.63%
OCF growth 3Y7.82%
OCF growth 5Y22.86%